EGRP News Flash - November 9, 2011

NCI Funding Opportunity Announcement Re-Issued for Program Project (P01) Applications

The National Cancer Institute (NCI) recently re-issued a Funding Opportunity Announcement (FOA) inviting applications for investigator-initiated Program Project (P01) grants. Proposed program projects may address any of the broad areas of cancer research, including (but not limited to) cancer biology, cancer treatment, cancer diagnosis, cancer prevention, and cancer control. Basic, translational, clinical, and/or population-based studies in all of these research areas are appropriate. Each Program Project application must consist of at least three component projects. The component projects must share a common central theme, focus, and/or overall objective.

The number of awards is contingent upon NIH appropriations, and the submission of a sufficient number of meritorious applications. Scope of the proposed project should determine the project period. The maximum period is 5 years.

Standard application due dates apply. Letters of intent are due 30 days prior to the anticipated application due date.

Applicants intending to submit applications with requested budgets of $500,000 or more in direct costs in any one year must contact the appropriate NCI program staff member and receive approval before submitting the proposal. The NIH Guide for Grants and Contracts states that approval must be sought 6 weeks prior to submitting such applications. However, approval for applications assigned to NCI's Division of Cancer Control and Population Sciences (DCCPS), of which the Epidemiology and Genomics Research Program (EGRP) is a part, must be sought in the form of an Awaiting Receipt of Application (ARA) at least eight weeks prior to submission to CSR or NCI in order to complete the necessary internal processing.

Investigators intending to submit a new P01 application are encouraged to contact their EGRP Program Director at least four months prior to the anticipated submission date to discuss application process.

The letter of intent should be sent to:

Referral Officer
Program Coordination and Referral Branch
Office of Referral, Review, and Program Coordination
Division of Extramural Activities
National Cancer Institute
6116 Executive Boulevard, Room 8040, MSC 8329
Bethesda, MD 20892-8329 (for U.S. Postal Service express or regular mail)
Rockville, MD 20852 (for non-USPS delivery)
Telephone: 301-496-3428
Fax: 301-402-0275
E-mail: ncirefof@dea.nci.nih.gov

Applications must be prepared using the PHS 398 research grant application forms and instructions for preparing a research grant application. Submit a signed, typewritten original of the application, including the checklist, and three signed photocopies in one package to:

Center for Scientific Review
National Institutes of Health
6701 Rockledge Drive, Room 1040, MSC 7710
Bethesda, MD 20892-7710 (U.S. Postal Service Express or regular mail)
Bethesda, MD 20817 (for express/courier service; non-USPS service)

At the time of submission, two identical, single-sided copies of the original application and all of the CDs with Appendix materials must be sent to:

Referral Officer
Program Coordination and Referral Branch
Office of Referral, Review, and Program Coordination
Division of Extramural Activities
National Cancer Institute
6116 Executive Boulevard, Room 8040, MSC 8329
Bethesda, MD 20892-8329 (for U.S. Postal Service express or regular mail)
Rockville, MD 20852 (for non-USPS delivery)
Telephone: 301-496-3428
Fax: 301-402-0275
E-mail: ncirefof@dea.nci.nih.gov

Access the NIH Guide for Grants and Contracts for details:

Return to Top